This week, the company participated in the "Bio-Life-Tech Conference" in Baltimore and received an award for the company most likely to receive funding.
"We are happy to receive encouragement from our peers that our business plan and technology have merit," said Urovalve, Inc. President and Chief Executive Officer Harvey D. Homan, PhD.
"We hope this kind of attention can increase our odds for future funding and support from the business community."
Urovalve, Inc. is a fledgling enterprise that holds patents on a device which can be implanted through the urethra into the bladder via a simple procedure that does not require surgery. The device contains a metal valve which opens whenever the user wants and is activated by a pocket-sized magnetic wand the user carries.
Urovalve's device will improve the quality of life for men who cannot urinate due to nerve damage, disease or physical problems that affect the urethra. "About 4.5 million men in the U.S. are believed to suffer from these problems," said Homan. For more information about Urovalve, please visit: http://www.urovalve.com
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
There was never a genius without a tincture of madness.